Xanthic Biopharma Inc. President, Gary Galitsky and Board Member, Dr. Gunther Hintz, Advance Cannabis Opportunity In Thailand
Loxo Oncology and Illumina to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
Revive Therapeutics Advances Research Program of Cannabinoid-Based Therapies Targeting Liver Diseases
Revive Therapeutics Announces Update on its Collaboration Agreement with Health Canada Licensed Dealer for Medical Cannabis…
Revive Therapeutics Appoints Blockchain Expert, Bernie Doyle, as Technical Advisor to Support Development of Medical Cannabis Patient-Focused Program Enabled by Blockchain and AI Technology
Revive Therapeutics Announces Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases
Cancer Genetics, Inc. to Receive $1.0 Million in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
